These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8071934)

  • 1. Isothiocyanate-substituted kappa-selective opioid receptor ligands derived from N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl] phenylacetamide.
    Weerawarna SA; Davis RD; Nelson WL
    J Med Chem; 1994 Sep; 37(18):2856-64. PubMed ID: 8071934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible binding of N-methyl-N-[(1S)-1-(4-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl-3,4 -dichlorophenylacetamide to the cloned rat kappa opioid receptor.
    Chen C; Yin J; Li JG; Xue JC; Weerawarna SA; Nelson WL; Liu-Chen LY
    Life Sci; 1997; 61(8):787-94. PubMed ID: 9275008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. kappa Opioid receptor selective affinity labels: electrophilic benzeneacetamides as kappa-selective opioid antagonists.
    Chang AC; Takemori AE; Ojala WH; Gleason WB; Portoghese PS
    J Med Chem; 1994 Dec; 37(26):4490-8. PubMed ID: 7799399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes.
    de Costa BR; Rice KC; Bowen WD; Thurkauf A; Rothman RB; Band L; Jacobson AE; Radesca L; Contreras PC; Gray NM
    J Med Chem; 1990 Nov; 33(11):3100-10. PubMed ID: 2172538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(3,4-Dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl]acetamide: an opioid receptor affinity label that produces selective and long-lasting kappa antagonism in mice.
    Chang AC; Takemori AE; Portoghese PS
    J Med Chem; 1994 May; 37(11):1547-9. PubMed ID: 8201586
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure/activity studies related to 2-(3,4-dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]acetamides: a novel series of potent and selective kappa-opioid agonists.
    Barlow JJ; Blackburn TP; Costello GF; James R; Le Count DJ; Main BG; Pearce RJ; Russell K; Shaw JS
    J Med Chem; 1991 Nov; 34(11):3149-58. PubMed ID: 1659636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of N-(1-benzylpiperidin-4-yl)arylacetamide analogues as potent sigma1 receptor ligands.
    Huang Y; Hammond PS; Wu L; Mach RH
    J Med Chem; 2001 Dec; 44(25):4404-15. PubMed ID: 11728186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guinea pig ileum preparation devoid of functional kappa receptors: a new in vitro pharmacologic assay for mu-opioid ligands.
    Schwartz RW; Chang AC; Portoghese PS; Berzetei-Gurske IP
    Life Sci; 1997; 60(15):PL235-9. PubMed ID: 9096250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.
    de Costa BR; Bowen WD; Hellewell SB; George C; Rothman RB; Reid AA; Walker JM; Jacobson AE; Rice KC
    J Med Chem; 1989 Aug; 32(8):1996-2002. PubMed ID: 2547074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of an affinity ligand ('UPHIT') for in vivo acylation of the kappa-opioid receptor.
    de Costa BR; Band L; Rothman RB; Jacobson AE; Bykov V; Pert A; Rice KC
    FEBS Lett; 1989 Jun; 249(2):178-82. PubMed ID: 2544446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes.
    Rothman RB; France CP; Bykov V; De Costa BR; Jacobson AE; Woods JH; Rice KC
    Eur J Pharmacol; 1989 Aug; 167(3):345-53. PubMed ID: 2553442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isothiocyanate-substituted benzyl ether opioid receptor ligands derived from 6 beta-naltrexol.
    Davis RD; Nelson WL
    J Med Chem; 1995 Feb; 38(3):570-9. PubMed ID: 7853350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylacetamide-derived fluorescent probes: synthesis, biological evaluation, and direct fluorescent labeling of kappa opioid receptors in mouse microglial cells.
    Chang AC; Chao CC; Takemori AE; Gekker G; Hu S; Peterson PK; Portoghese PS
    J Med Chem; 1996 Apr; 39(8):1729-35. PubMed ID: 8648612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
    Cappelli A; Anzini M; Vomero S; Menziani MC; De Benedetti PG; Sbacchi M; Clarke GD; Mennuni L
    J Med Chem; 1996 Feb; 39(4):860-72. PubMed ID: 8632410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.
    Anzini M; Canullo L; Braile C; Cappelli A; Gallelli A; Vomero S; Menziani MC; De Benedetti PG; Rizzo M; Collina S; Azzolina O; Sbacchi M; Ghelardini C; Galeotti N
    J Med Chem; 2003 Aug; 46(18):3853-64. PubMed ID: 12930147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic activity and opioid receptor selectivity of stereoisomers of ohmefentanyl isothiocyanate.
    Chen BY; Jin WQ; Chen XJ; Zhu YC; Chi ZQ
    Eur J Pharmacol; 2001 Jul; 424(3):195-8. PubMed ID: 11672562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists.
    Costello GF; James R; Shaw JS; Slater AM; Stutchbury NC
    J Med Chem; 1991 Jan; 34(1):181-9. PubMed ID: 1846918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
    Childers SR; Xiao R; Vogt L; Sim LJ
    Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.